(Q56898282)

English

Pharmacokinetics of venlafaxine extended release 75 mg and desvenlafaxine 50 mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study

No description defined

In more languages

Statements

scholarly article

0 references

Pharmacokinetics of venlafaxine extended release 75 mg and desvenlafaxine 50 mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study (English)

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Alice I Nichols

1

0 references

Kristen Focht

2

0 references

Qin Jiang

3

0 references

Sheldon H Preskorn

4

0 references

Cecelia P Kane

5

0 references

language of work or name

0 references

publication date

2011

0 references

Clinical Drug Investigation

0 references

31

0 references

3

0 references

155-67

0 references

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activity

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Pharmacogenetics of the cytochromes P450.

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

The association between cytochrome P450 2D6 genotype and prescription patterns of antipsychotic and antidepressant drugs in hospitalized psychiatric patients: a retrospective follow-up study.

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity.

1 reference

https://api.crossref.org/works/10.2165%2F11586630-000000000-00000

21 January 2018

The impact of Cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21288052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21288052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/21288052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/21288052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP2D6 testing in breast cancer: ready for prime time?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21288052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21288052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reproducibility of the in vivo effect of the selective serotonin reuptake inhibitors on the in vivo function of cytochrome P450 2D6: an update (part I)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21288052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man

1 reference

https://pubmed.ncbi.nlm.nih.gov/21288052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11586630-000000000-00000

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56898282&oldid=1544024299"